Briefing Summary: US FDA Posts Advisory Committee Materials for Discussion About How to Streamline Clinical Trial Development for Antibacterial Products – DEC 4, 2014 (AIDAC)

The US FDA has posted details, including FDA Briefing Materials, for the Thursday, December 4, 2014 Anti-Infective Drugs Advisory Committee (AIDAC) Meeting. The committee will discuss issues related to clinical development programs and clinical trial designs for antibacterial products for the treatment of patients with serious bacterial infections for which there are limited or no therapeutic options. They will review ways in which to streamline development.

See the SAC Tracker Report